in general, the weight and height gain of pediatric patients treated with strattera lags behind that predicted by normative population data for about the first 9 12 months of treatment. subsequently weight gain rebounds and at about 3 years of treatment, patients treated with strattera have gained 17.9 kg on average, g 5 kg more than predicted by their baseline data.